RETRACTED: Hydrogen-rich saline reduces oxidative stress and inflammation by inhibit of JNK and NF-κB activation in a rat model of amyloid-beta-induced Alzheimer’s disease
Wang Cai, Li Jian, Liu Qiang, Yang Rui, Zhang John H., Cao Yun-Peng, Sun Xue-Jun · Neuroscience Letters · 2011
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
Molecular hydrogen produced a favorable primary result in this animal study, supporting further research into its potential for alzheimer’s disease.
Hydrogen-rich saline alzheimer’s disease study 2011: what the findings mean
This H2HUBB page translates the technical study record into consumer-friendly language while preserving the scientific details. This animal study examined RETRACTED: Hydrogen-rich saline reduces oxidative stress (an imbalance in which reactive molecules exceed the body’s ability to control them) and inflammation by inhibit of JNK and NF-κB (a protein pathway that regulates many inflammatory genes) activation in a rat model of amyloid-beta-induced Alzheimer’s disease. The abstract describes Rat model; sample size 18; hydrogen delivered as hydrogen-rich saline and injected or infused hydrogen; reported duration 10 days.
Publication: Wang Cai, Li Jian, Liu Qiang, Yang Rui, Zhang John H., Cao Yun-Peng, Sun Xue-Jun, Neuroscience Letters, 2011.
What the researchers studied
The levels of IL-1β were assessed by ELISA analysis, 8-OH-dG by immunohistochemistry in the brain slides, and JNK and NF-κB (a protein pathway that regulates many inflammatory genes) by immunohistochemistry and western…
What effects did molecular hydrogen have?
Observed hydrogen effects: This study is to examine if hydrogen-rich saline reduced amyloid-beta (Aβ) induced neural inflammation and oxidative stress (an imbalance in which reactive molecules exceed the body’s ability to control them) in a rat model by attenuation of activation of JNK and NF-κB (a protein pathway that regulates many inflammatory genes). After Aβ1-42 injection, the level of IL-1β, 8-OH-dG, JNK and NF-κB all increased in brain tissues, while hydrogen-rich saline treatment decreased the level of IL-1β, 8-OH-dG and the activation of JNK and NF-κB.
Why these findings matter
The result supports the biological and therapeutic potential of hydrogen-rich saline for alzheimer’s disease. It shows that hydrogen affected meaningful outcomes in an animal model, but it does not prove that the same benefit will occur in people.
How strong is this evidence?
This is preclinical animal evidence. It can show biological effects in a whole living system, but human effectiveness and dosing still require clinical trials. The reported sample size was 18.
Technical study details
- Publication type: Animal study
- Evidence type: Preclinical animal evidence
- Research model or population: Rat model
- Sample size: 18
- Hydrogen method: Hydrogen-rich saline
- Dose or treatment amount: 330 g
- Treatment duration: 10 days
Limitations and safety
Important limitations: Preclinical animal findings may not translate directly to human outcomes. The intervention or follow-up period appears relatively short.
Safety information: The abstract did not provide detailed safety or adverse-event information.
Original study and H2HUBB research context
This page explains a published research record and does not turn one study into a medical recommendation. Read the original scientific source for the complete methods, statistics, and author conclusions. Compare this result with related evidence in the H2HUBB Molecular Hydrogen Research Library.